Isaac Zacharias - 15 Jun 2021 Form 4 Insider Report for Shockwave Medical, Inc.

Signature
/s/ Wade Estey, as attorney in fact for Isaac Zacharias
Issuer symbol
N/A
Transactions as of
15 Jun 2021
Net transactions value
-$726,153
Form type
4
Filing time
16 Jun 2021, 19:25:55 UTC
Previous filing
27 May 2021
Next filing
16 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $26,840 +4,000 +6.7% $6.71* 63,420 15 Jun 2021 Direct F1
transaction SWAV Common Stock Sale $111,528 -600 -0.95% $185.88 62,820 15 Jun 2021 Direct F2
transaction SWAV Common Stock Sale $168,624 -900 -1.4% $187.36 61,920 15 Jun 2021 Direct F3
transaction SWAV Common Stock Sale $215,021 -1,141 -1.8% $188.45 60,779 15 Jun 2021 Direct F4
transaction SWAV Common Stock Sale $150,619 -796 -1.3% $189.22 59,983 15 Jun 2021 Direct F5
transaction SWAV Common Stock Sale $107,201 -563 -0.94% $190.41 59,420 15 Jun 2021 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Employee Stock Option (Right to Buy) Options Exercise $0 -4,000 -6.2% $0.000000 60,322 15 Jun 2021 Common Stock 4,000 $6.71 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 9/10/2020.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $185.39 to $186.11. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $186.84 to $187.79. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $187.95 to $188.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $188.98 to $189.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $190.00 to $190.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 Twenty-five percent of the shares subject to the option vested on 11/9/2019 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.